MNMD•benzinga•
Roth Capital Initiates Coverage On Mind Medicine with Buy Rating, Announces Price Target of $7
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 4, 2022 by benzinga